Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile
NCI

NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile

September 10, 2021
Vol.47 No.33
By Matthew Bin Han Ong
As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved
Conversation with The Cancer Letter

As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved

September 10, 2021
Vol.47 No.33
By Paul Goldberg
Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors
Capitol HillFree

Congressional letter based on Grothey case demands answers on NIH policies on sexual misconduct by advisors

September 03, 2021
Vol.47 No.32
By Paul Goldberg and Matthew Bin Han Ong
Cancer Crusade tells the gripping story of the National Cancer Act
Cancer History ProjectFree

Cancer Crusade tells the gripping story of the National Cancer Act

August 06, 2021
Vol.47 No.31
By Otis W. Brawley and Paul Goldberg
The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
Cancer History ProjectFree

The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
“There couldn’t be a better time to be in oncology”

August 06, 2021
Vol.47 No.31
By Katie Goldberg and Alexandria Carolan
Racial minority patients underrepresented in 80% of hospitals, U.S. News “equity measures” find
FreeHealth Equity

Racial minority patients underrepresented in 80% of hospitals, U.S. News “equity measures” find

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Ben Harder: U.S. News may use health equity measures to rank hospitals in the future
Conversation with The Cancer LetterFreeHealth Equity

Ben Harder: U.S. News may use health equity measures to rank hospitals in the future

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Should hospitals, cancer centers be ranked according to their health equity scorecards?
FreeHealth Equity

Should hospitals, cancer centers be ranked according to their health equity scorecards?
Winn, Knudsen, Mesa, Willman discuss the health equity measures introduced by U.S. News & World Report

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law
Capitol HillFree

Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law

July 23, 2021
Vol.47 No.29
By Matthew Bin Han Ong
House subcommittee slates $6.5B increase for NIH: $3B for ARPA-H and $3.5B for research, adding $432M to FY22 NCI budget
Capitol Hill

House subcommittee slates $6.5B increase for NIH: $3B for ARPA-H and $3.5B for research, adding $432M to FY22 NCI budget

July 16, 2021
Vol.47 No.28

Posts navigation

Previous1…36373839Next

Trending Stories

  • OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
  • Peter F. Garrett to people with cancer: Your story has power
  • What NHS-Galleri taught us—and what it didn’t
  • As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
    The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded
  • The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
  • FDA clears a way for dramatic reduction in animal toxicology studies in cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account